.Observing a bad showing for Lykos Therapeutics' MDMA prospect for post-traumatic stress disorder at...
.AN2 Therapeutics is actually re-thinking its own organization in feedback to poor midphase data, pl...
.Merck & Co. is paying for $700 thousand ahead of time to test Amgen in a blood cancer market. Th...
.Along With Gilead Sciences on the verge of an FDA selection for its liver ailment medicine seladelp...
.CEO David Ricks can observe the providers putting together outdoors tents at basecamp behind Eli Li...
.Mattress Liquidators has transformed Entero Therapeutics white colored as a sheet. The financial in...
.Exelixis is losing hope on its own tissue variable (TF)- targeting antibody-drug conjugate after co...
.3 full weeks after Roche's Genentech unit left an SHP2 inhibitor deal, Relay Therapeutics has actua...
.Stoke Therapies' Dravet disorder medication has been without a predisposed grip, getting rid of the...
.Intense Biotech Partner Editor Gabrielle Masson offered the 2024 course of Brutal 15 victors on the...